Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

The White House has secured another deal with major pharmaceutical companies, this time to offer popular weight loss drugs ...

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...

According to recent Gallup data, obesity rates in the United States fell back down to 37 percent this year, from hitting a ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

NBC News confirms the Trump administration is preparing to announce a deal to sell Wegovy and Zepbound for as little as $149 ...

Health and Human Services Secretary Robert F. Kennedy Jr. said Thursday’s deal was the biggest of the pharmaceutical deals ...

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...

The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...